236 related articles for article (PubMed ID: 32815131)
41. Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.
Grenier D; Roy S; Chandad F; Plamondon P; Yoshioka M; Nakayama K; Mayrand D
Infect Immun; 2003 Aug; 71(8):4742-8. PubMed ID: 12874356
[TBL] [Abstract][Full Text] [Related]
42. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.
Kuboniwa M; Amano A; Shizukuishi S; Nakagawa I; Hamada S
Infect Immun; 2001 May; 69(5):2972-9. PubMed ID: 11292714
[TBL] [Abstract][Full Text] [Related]
43. Structural insights unravel the zymogenic mechanism of the virulence factor gingipain K from
Pomowski A; Usón I; Nowakowska Z; Veillard F; Sztukowska MN; Guevara T; Goulas T; Mizgalska D; Nowak M; Potempa B; Huntington JA; Potempa J; Gomis-Rüth FX
J Biol Chem; 2017 Apr; 292(14):5724-5735. PubMed ID: 28196869
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of vimF, a putative glycosyltransferase gene downstream of vimE, alters glycosylation and activation of the gingipains in Porphyromonas gingivalis W83.
Vanterpool E; Roy F; Fletcher HM
Infect Immun; 2005 Jul; 73(7):3971-82. PubMed ID: 15972484
[TBL] [Abstract][Full Text] [Related]
45. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel Porphyromonas gingivalis outer membrane protein, PG534, required for the production of active gingipains.
Saiki K; Konishi K
FEMS Microbiol Lett; 2010 Sep; 310(2):168-74. PubMed ID: 20695897
[TBL] [Abstract][Full Text] [Related]
47. Lysine-specific gingipain K and heme/hemoglobin receptor HmuR are involved in heme utilization in Porphyromonas gingivalis.
Simpson W; Olczak T; Genco CA
Acta Biochim Pol; 2004; 51(1):253-62. PubMed ID: 15094847
[TBL] [Abstract][Full Text] [Related]
48. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
[TBL] [Abstract][Full Text] [Related]
49. A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy.
Kataoka S; Baba A; Suda Y; Takii R; Hashimoto M; Kawakubo T; Asao T; Kadowaki T; Yamamoto K
FASEB J; 2014 Aug; 28(8):3564-78. PubMed ID: 24776743
[TBL] [Abstract][Full Text] [Related]
50. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
Sugawara S; Nemoto E; Tada H; Miyake K; Imamura T; Takada H
J Immunol; 2000 Jul; 165(1):411-8. PubMed ID: 10861079
[TBL] [Abstract][Full Text] [Related]
51. Mixed infection of Porphyromonas gingivalis and Bacteroides forsythus in a murine abscess model: involvement of gingipains in a synergistic effect.
Yoneda M; Hirofuji T; Anan H; Matsumoto A; Hamachi T; Nakayama K; Maeda K
J Periodontal Res; 2001 Aug; 36(4):237-43. PubMed ID: 11519697
[TBL] [Abstract][Full Text] [Related]
52. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes.
Potempa J; Sroka A; Imamura T; Travis J
Curr Protein Pept Sci; 2003 Dec; 4(6):397-407. PubMed ID: 14683426
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of gingipains by their profragments as the mechanism protecting Porphyromonas gingivalis against premature activation of secreted proteases.
Veillard F; Sztukowska M; Mizgalska D; Ksiazek M; Houston J; Potempa B; Enghild JJ; Thogersen IB; Gomis-Rüth FX; Nguyen KA; Potempa J
Biochim Biophys Acta; 2013 Aug; 1830(8):4218-28. PubMed ID: 23583629
[TBL] [Abstract][Full Text] [Related]
54. Lipoprotein modifications by gingipains of Porphyromonas gingivalis.
Lönn J; Ljunggren S; Klarström-Engström K; Demirel I; Bengtsson T; Karlsson H
J Periodontal Res; 2018 Jun; 53(3):403-413. PubMed ID: 29341140
[TBL] [Abstract][Full Text] [Related]
55. Structure of the lysine specific protease Kgp from Porphyromonas gingivalis, a target for improved oral health.
Gorman MA; Seers CA; Michell BJ; Feil SC; Huq NL; Cross KJ; Reynolds EC; Parker MW
Protein Sci; 2015 Jan; 24(1):162-6. PubMed ID: 25327141
[TBL] [Abstract][Full Text] [Related]
56. A role for gingipains in cellular responses and bacterial survival in Porphyromonas gingivalis-infected cells.
Kadowaki T; Takii R; Yamatake K; Kawakubo T; Tsukuba T; Yamamoto K
Front Biosci; 2007 Sep; 12():4800-9. PubMed ID: 17569610
[TBL] [Abstract][Full Text] [Related]
57. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model--involvement of gingipains and responses to re-infection.
Yoneda M; Hirofuji T; Motooka N; Anan H; Hamachi T; Miura M; Ishihara Y; Maeda K
J Periodontal Res; 2003 Dec; 38(6):551-6. PubMed ID: 14632916
[TBL] [Abstract][Full Text] [Related]
58. Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis.
Kuboniwa M; Amano A; Hashino E; Yamamoto Y; Inaba H; Hamada N; Nakayama K; Tribble GD; Lamont RJ; Shizukuishi S
BMC Microbiol; 2009 May; 9():105. PubMed ID: 19470157
[TBL] [Abstract][Full Text] [Related]
59. Gingipain RgpB is excreted as a proenzyme in the vimA-defective mutant Porphyromonas gingivalis FLL92.
Olango GJ; Roy F; Sheets SM; Young MK; Fletcher HM
Infect Immun; 2003 Jul; 71(7):3740-7. PubMed ID: 12819055
[TBL] [Abstract][Full Text] [Related]
60. Degradation of vascular endothelial thrombomodulin by arginine- and lysine-specific cysteine proteases from Porphyromonas gingivalis.
Inomata M; Ishihara Y; Matsuyama T; Imamura T; Maruyama I; Noguchi T; Matsushita K
J Periodontol; 2009 Sep; 80(9):1511-7. PubMed ID: 19722803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
